Clinical trial

ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical…

NCT00396461 · B. Braun Medical SA, Industry · Terminated

Key facts

NCT number NCT00396461
Title ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients
Official title Phase IV-IV. ICULIP,a Prospective,Multi-centre,Randomised,Comparative,Double-blind Study to Evaluate Two Different Types of Lipid Emulsions Used for Total Parenteral Nutrition in Critical Patients and Their Influence on Nosocomial Infection.
Acronym ICULIP
Lead sponsor B. Braun Medical SA, Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Critical Illness
Intervention type Drug
Interventions MCT/LCT (1:1), MCT/LCT/omega-3 (5:4:1)
Enrollment 212
Start date Nov 1, 2006
Primary completion Sep 1, 2010
Completion Feb 1, 2011
First posted Nov 7, 2006
Last update posted Jul 19, 2013
Countries Spain

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies